Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
+36,400
New +$1.35M 0.05% 400
2023
Q4
– Sell
-6,196
Closed -$266K – 840
2023
Q3
$266K Buy
+6,196
New +$289K 0.02% 583
2020
Q3
– Sell
-173,464
Closed -$7.87M – 1585
2020
Q2
$7.87M Hold
173,464
– – 0.2% 85
2020
Q1
$7.65M Buy
173,464
+250
+0.1% +$9.77K 0.2% 117
2019
Q4
$6.21M Sell
173,214
-166,057
-49% -$6.17M 0.09% 399
2019
Q3
$11.9M Buy
339,271
+7,200
+2% +$277K 0.14% 190
2019
Q2
$14.3M Sell
332,071
-48,161
-13% -$2M 0.28% 140
2019
Q1
$16.4M Sell
380,232
-53,399
-12% -$2.15M 0.33% 115
2018
Q4
$15.8M Buy
433,631
+45,096
+12% +$1.67M 0.34% 100
2018
Q3
$15.6M Buy
388,535
+256,588
+194% +$10.3M 0.33% 103
2018
Q2
$5.06M Sell
131,947
-149,041
-53% -$5.48M 0.13% 278
2018
Q1
$9.63M Sell
280,988
-53,047
-16% -$1.86M 0.27% 90
2017
Q4
$11M Sell
334,035
-171,465
-34% -$5.91M 0.32% 79
2017
Q3
$16.9M Buy
505,500
+81,134
+19% +$2.8M 0.54% 47
2017
Q2
$15.1M Buy
+424,366
New +$14.3M 0.44% 62

Other funds holding QGEN

Winton Group's QGEN Position: Q2 2026 in Review

Winton Group opened a new position in Qiagen (QGEN) in Q2 2026: 36,400 shares worth $1.42M. The stake represents 0.05% of the portfolio and ranks #400 among its holdings. This is a return to the name: Winton Group previously reported a position in QGEN as recently as Q3 2023.

Winton Group first reported a position in QGEN in Q2 2017 and has held it in 15 quarters since. The position peaked at $16.9M in Q3 2017. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Winton Group held 36,400 shares of Qiagen worth $1.42M as of Q2 2026.
  • Qiagen was a new Winton Group position in Q2 2026.
  • Qiagen made up 0.05% of Winton Group's portfolio in Q2 2026, its #400 holding.
  • Winton Group first reported a position in Qiagen in Q2 2017 and has held it in 15 quarters since.
  • Winton Group's Qiagen position peaked at $16.9M in Q3 2017.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.